Topic: How To Invest

Q: What’s your opinion of Tilray? It hit a peak last year at $300, and is now trading around $30. Thanks.

Article Excerpt

A: Tilray, $31.00, symbol TLRY on Nasdaq (Shares outstanding: 97.4 million; Market cap: $3.0 billion; www.tilray.com), completed an initial public offering of 10.35 million common shares at $17.00 U.S. a share on July 19, 2018. Tilray is a Canadian-based medical marijuana producer, which began operating in 2013. At the time of its 2018 IPO, the company sold cannabis products to tens of thousands of patients in 10 countries: Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand and South Africa. That number has now expanded to 13 countries. Tilray supplies those markets through its subsidiaries in Australia, Canada and Germany. The company also has agreements with established pharmaceutical distributors. All of Tilray’s medical cannabis cultivation takes place in the provinces of B.C. and Ontario, and now Portugal. It is, however, making acquisitions to expand its business beyond medical cannabis. For example, in March 2019, the company completed the acquisition of hemp producer Manitoba Harvest for $317 million. That Winnipeg-based firm makes hemp-based granola,…